Pseudomonas Infections
Information
- Disease name
- Pseudomonas Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00014950 | Completed | N/A | Benefits and Risks of Newborn Screening for Cystic Fibrosis | ||
| NCT00235690 | Completed | N/A | Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) | June 2008 | August 2015 |
| NCT00634192 | Completed | Phase 3 | Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin | February 2008 | August 2009 |
| NCT03044223 | Recruiting | Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis | August 2014 | December 2026 | |
| NCT00621803 | Terminated | N/A | Lcr35 / ICU / P. Aeruginosa | March 2003 | October 2005 |
| NCT00610623 | Terminated | Phase 2 | Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia | April 2003 | October 2005 |
| NCT03715322 | Unknown status | Phase 3 | Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa | October 26, 2018 | June 2021 |
| NCT03510351 | Unknown status | Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections | February 1, 2017 | February 28, 2019 | |
| NCT03638830 | Unknown status | Phase 2 | Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa | October 17, 2018 | January 31, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011552